J Mol Cell Cardiol September 2021 PMID 34081950

An evolutionarily-conserved promoter allele governs HMG-CoA reductase expression in spontaneously hypertensive rat.

Abrar A Khan, Poovitha Sundar, Bhargavi Natarajan, Vinayak Gupta, Vikas Arige, S Santosh Reddy, Manoj K Barthwal, Nitish R Mahapatra

Full text PDF Download social card

Mentions

Peak: 4 in Nov 2025

across 2 sources since Sep 2025

Extended reach

131

potential audience

Total likes

Video views

Mentions per month

Sep 2025 – Nov 2025

Where it's discussed

YouTube3 videos
X / Twitter2 posts

AI synopsis

What people are saying

The discussions reflect a general appreciation for the genetic insights provided by the research, with remarks such as 'evolutionarily-conserved', and references to the molecular mechanisms like transcription factor binding. The tone is informative yet reserved, with comments like 'interesting implications for hypertension' indicating moderate engagement without extensive debate or enthusiasm.

AgreementModerate agreement

Most discussions acknowledge the significance of genetic regulation in hypertension and cholesterol levels.

InterestModerate interest

Participants show moderate curiosity, often mentioning the evolutionary aspect and the molecular details.

EngagementNeutral engagement

Comments tend to be brief, with some references to broader implications but few deep dives.

ImpactModerate impact

The post suggests recognition of the study's potential influence on understanding cardiovascular genetics, but few predict direct applications.

Abstract in brief

The study investigated how genetic differences in the HMG-CoA reductase (Hmgcr) gene promoter influence its expression in spontaneously hypertensive rats (SHR) compared to normotensive Wistar-Kyoto (WKY) rats, revealing that lower Hmgcr levels in SHR are linked to specific promoter variations.
A key variation at an evolutionarily conserved site (A405G) reduces promoter activity in SHR by affecting the binding of transcription factors Runx3 and Srebf1, leading to decreased Hmgcr expression and lower cholesterol levels.
The findings provide a molecular explanation for the reduced circulating cholesterol in SHR, a common model for cardiovascular disease, highlighting how genetic promoter differences can impact gene regulation and disease risk.]

Read the full abstract